GlassScriptPhysician profile
Kara E Paxton
NPI 1851178834
$2,916.80
in general payments reported to CMS, 2019-2025
30 companies · $1,025 in 2025
The $1,025 reported for 2025 was more than what 88% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $387 · 2024: $1,505 · 2025: $1,025.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,917.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,916.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $628.22 | 2024-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $285.57 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $224.38 | 2023-2025 | Lokelma, Farxiga |
| E.R. Squibb & Sons, L.L.C. | $199.17 | 2023-2025 | Camzyos, Eliquis |
| Abbott Laboratories | $169.35 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Philips North America LLC | $153.37 | 2024-2025 | (5044) Mcot, Mcot, (5050) Extended Holter |
| Novo Nordisk INC | $125.63 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Abiomed | $117.69 | 2024 | Impella |
| Alnylam Pharmaceuticals INC. | $107.82 | 2024-2025 | Onpattro, Amvuttra |
| Cardiva Medical, INC. | $83.17 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Amgen INC. | $82.78 | 2024-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $81.30 | 2023-2025 | Watchman Access System, Lux-Dx Insertable Cardiac Monitor |
| Lilly USA, LLC | $74.65 | 2024-2025 | Zepbound, Jardiance |
| Biosense Webster, INC. | $72.84 | 2023-2025 | Carto 3, Nuvision Ice Catheter |
| Atricure, INC. | $63.79 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System, Synergy Ablation System |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $53.59 | 2023-2024 | Na, Ffrangio, Micra |
| Heartflow, INC. | $45.55 | 2023-2024 | Ffrct |
| Cvrx, INC. | $42.10 | 2025 | Barostim Neo System |
| Impulse Dynamics (USA) INC. | $39.46 | 2024 | Optimizer |
| Medicomp INC | $35.64 | 2024 | Telepatch Cardiac Monitor |
| Bridgebio Pharma, INC. | $35.45 | 2025 | Attruby |
| Ionis Pharmaceuticals, INC. | $34.23 | 2025 | Tryngolza |
| Scpharmaceuticals INC. | $28.20 | 2025 | |
| Daiichi Sankyo INC. | $24.39 | 2023 | Injectafer |
| Regeneron Healthcare Solutions, INC. | $23.58 | 2024 | Evkeeza |
| Bayer Healthcare Pharmaceuticals INC. | $20.10 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $19.92 | 2023 | Inpefa |
| Kestra Medical Technology Services, INC. | $16.97 | 2024 | Assure Wcd |
| Merck Sharp & Dohme LLC | $13.96 | 2025 | Verquvo |
| Altathera Pharmaceuticals LLC | $13.93 | 2024 | Sotalol Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kara Paxton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.